Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-20-001282
Filing Date
2020-04-24
Accepted
2020-04-24 17:03:05
Documents
1
Period of Report
2020-05-07
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY cns_def14a.htm DEF 14A 355269
  Complete submission text file 0001683168-20-001282.txt   356332
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39126 | Film No.: 20815906
SIC: 2834 Pharmaceutical Preparations